To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 11,980 shares, the number of shares held increased 2.57% compared to the previous period and now represents 3.9% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 41,680 shares, the number of shares held increased 2.57% compared to the previous period and now represents 2.34% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 266,200 shares, the number of shares held increased 2.57% compared to the previous period and now represents 1.42% of the total position.
      5.99K3
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 50,160 shares, the number of shares held increased 2.57% compared to the previous period and now represents 8.54% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 53,700 shares, the number of shares held increased 2.57% compared to the previous period and now represents 5.17% of the total position.
      117Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 119,120 shares, the number of shares held increased 2.57% compared to the previous period and now represents 1.63% of the total position.
      16Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 127,000 shares, the number of shares held increased 2.57% compared to the previous period and now represents 2.04% of the total position.
      31Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 8,680 shares, the number of shares held increased 2.57% compared to the previous period and now represents 2.4% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 12,160 shares, the number of shares held increased 2.57% compared to the previous period and now represents 0.58% of the total position.
      165Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 50,620 shares, the number of shares held increased 2.57% compared to the previous period and now represents 2.3% of the total position.
      37Comment
      Report
       
       
       
       

      Most Discussed